Download presentation
Presentation is loading. Please wait.
Published byLanny Susman Modified over 5 years ago
1
Stimulation and/or Surgical Approaches for Intractable OCD
Darin D. Dougherty, MD MMSc Director, Division of Neurotherapeutics Department of Psychiatry Massachusetts General Hospital Associate Professor of Psychiatry Harvard Medical School
2
Disclosures (last 12 months)
Research Support: None Honoraria: Medtronic
3
Current OCD Model
5
Psychiatric Neurotherapeutics
Definition = surgical & device-based treatments Electroconvulsive therapy (ECT) Vagus Nerve Stimulation (VNS) Transcranial Magnetic Stimulation (TMS)* Psychiatric Neurosurgery Lesion (ablative) procedures* Deep Brain Stimulation (DBS)* * relevant to today’s presentation
6
rTMS
7
General Principles Uses magnetic field introduced on scalp surface to generate electrical stimulation of focal areas of brain cortex Unlike ECT, does not involve general anesthesia of seizures Approved by US FDA for use in treatment of depression
11
Clinical Efficacy for OCD
Multiple rTMS targets for OCD have been explored The DLPFC (depression target, approved by FDA for depression) has, generally, not been found to be efficacious for OCD Only two controlled trials of rTMS for OCD have been positive, each at a different (but similar) target: the dmPFC and pre-SMA
12
Ablative Limbic System Surgery
13
Prior Treatment Criteria
Ensure: Multiple serial adequate trials of antidepressants Adequate trial of multiple serial augmentation strategies Adequate trials of alternative monotherapies Adequate trial of psychotherapy (especially CBT) Adequate trial of ECT
14
Anterior Cingulotomy
15
Anterior Cingulotomy
16
Effectiveness of Cingulotomy for OCD
Total n =64; mean f/u = 63.8 months Full response (35%+ YBOCS improvement) = 47% Partial response (25-34% YBOCS improvement) = 22% Minimal adverse events Sheth SA, Neal J, Frances Tangherlini F, Mian MK, Andre Gentil A, Cosgrove GR, Eskandar EN, Dougherty DD. Cingulotomy for treatment-refractory obsessive-compulsive disorder: a prospective long-term follow-up of 64 patients. J Neurosurg Dec 14. [Epub ahead of print]
17
Rauch SL, Dougherty DD, Cosgrove GR, Cassem EH, Alpert NM, Price BH, Nierenberg AA, Mayberg HS, Baer L, Jenike MA, Fischman AJ. Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder. Biol Psychiatry 2001; 50:
18
Deep Brain Stimulation
20
S1 S4 S3 S2 Coronal T1 or T2 (when T1 not available) MRI scans of the four patients (S1-S4), demonstrating electrode placement. Patient #1: 33F Patient #2: 24F Patient #3: 52F Patient #4: 55M
21
Dorsolateral Premotor Motor 1 2 3 Orbital Medial Courtesy of SN Haber
22
DBS Patient Demographics*
Mean (years) Minimum (years) Maximum (years) Age at Implantation 37.1 22.0 59.0 Age at OCD Onset 15.1 7.0 34.0 Symptom Duration 8.0 41.0 Gender M = 53.8% F = 46.2% History of Depression Yes = 88.5% No = 11.5% * Reclaim DBS Therapy for OCD - Lead Kit for Deep Brain Stimulation Implant Manual; part number MA10549A002. 22
23
Percent Change Y-BOCS Score Follow-up Period (months)
Y-BOCS Scale Percent of Improvement with DBS Follow-up Study Results All Subjects Responders Only -10 * -20 Percent Change Y-BOCS Score -30 * * * * * -40 -50 -60 1 3 6 12 24 36 N=25 N=26 N=24 N=21 N=17 N=12 Baseline Follow-up Period (months) * Within-subject change statistically significant (p ≤ .001, two-sided test). 23
24
Follow-up Period (months)
GAF Scale Improvement in Score with DBS Follow-up Study Results 70 * 60 * * * * * Average GAF Score 50 40 30 Baseline 1 3 6 12 24 36 N=21 N=20 N=21 N=20 N=18 N=16 N=12 Follow-up Period (months) * Within-subject change statistically significant (p ≤ .001, two-sided test). 24
25
VC/VS DBS for OCD Approved by FDA under the HDE mechanism in 2009
Reimbursed by third party payers
26
Future Directions: Closed Loop DBS
27
Collaborators Massachusetts General Hospital
Psychiatric Neurosurgery Committee Emad Eskandar, Darin Dougherty, Cris Cusin, Karleyton Evans, Alice Flaherty, Bruce Price, Scott Rauch (emeritus) Center for Morphometric Analysis Nikos Makris, David Kennedy, Verne Caviness PET Laboratory Tom Brady, Alan Fischman, Nat Alpert Butler Hospital Site Ben Greenberg, Steve Rasmussen, et al Cleveland Clinic Site Don Malone, Ali Rezai et al University of Florida Site Wayne Goodman et al Medical College Wisconsin Brian Koppell et al
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.